Antibiotice Ia Financial Flexibility Index

Latest as of June 2026: 0.11x

Antibiotice Ia financial flexibility index. Antibiotice Ia (ATB) has a Financial Flexibility Index of 0.11x as of June 2026. Free cash flow of RON67.96 Million (operating CF RON18.71 Million minus capex RON49.25 Million) represents 0% of total liabilities (RON623.78 Million). See ATB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Financial Flexibility Index

0.11x
Free Cash Flow / Total Liabilities

Free Cash Flow

RON67.96 Million
Operating CF − Capex

Total Liabilities

RON623.78 Million
RON

Capital Expenditures

RON49.25 Million
RON

Financial Flexibility Index of Antibiotice Ia (2022–2025)

Financial flexibility index of Antibiotice Ia from 2022 to 2025. Historical Financial Flexibility Index trend for Antibiotice Ia across 4 annual periods. Check Antibiotice Ia (ATB) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Antibiotice Ia Financial Flexibility Index by Year (2022–2025)

Antibiotice Ia financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Antibiotice Ia. For the full cash flow conversion analysis, see Antibiotice Ia (ATB) cash flow conversion.

Year Flexibility Index Free Cash Flow (RON) Operating CF Total Liabilities YoY Change
2025 0.47x RON215.05 Million RON72.44 Million RON460.49 Million ▼ -14.9%
2024 0.55x RON211.31 Million RON95.15 Million RON384.95 Million ▼ -27.3%
2023 0.75x RON220.50 Million RON122.46 Million RON292.21 Million ▲ +4.3%
2022 0.72x RON155.54 Million RON115.66 Million RON215.04 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities